ADMA
ADMA Biologics, Inc. Healthcare - Biotechnology Investor Relations →
ADMA Biologics, Inc. (ADMA) closed at $16.43 as of 2026-02-02, trading 68.0% above its 200-week moving average of $9.78. The stock is currently moving closer to the line, down from 78.2% last week. The 14-week RSI sits at 54, indicating neutral momentum.
Over the past 594 weeks of data, ADMA has crossed below its 200-week moving average 5 times. On average, these episodes lasted 78 weeks. The average one-year return after crossing below was -23.3%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $3.9 billion, ADMA is a mid-cap stock. The company generates a free cash flow yield of 0.1%. Return on equity stands at 63.2%, indicating strong profitability. The stock trades at 9.1x book value.
Share count has increased 20.8% over three years, indicating dilution. ADMA passes our Buffett quality screen: high return on equity, low debt, and positive free cash flow.
Over the past 11.5 years, a hypothetical investment of $100 in ADMA would have grown to $143, compared to $426 for the S&P 500. ADMA has returned 3.2% annualized vs 13.4% for the index, underperforming the broader market over this period.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Growth of $100: ADMA vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After ADMA Crosses Below the Line?
Across 5 historical episodes, buying ADMA when it crossed below its 200-week moving average produced an average return of -12.6% after 12 months (median -16.0%), compared to +9.6% for the S&P 500 over the same periods. 20% of those episodes were profitable after one year. After 24 months, the average return was +95.4% vs +37.2% for the index.
Each line shows $100 invested at the moment ADMA crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
ADMA has crossed below its 200-week MA 5 times with an average 1-year return of +-23.3% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Mar 2015 | Jun 2015 | 17 | 17.8% | -45.0% | +78.4% |
| Jul 2015 | Oct 2015 | 11 | 8.5% | -26.6% | +80.0% |
| Oct 2015 | Sep 2019 | 203 | 69.6% | -32.5% | +77.4% |
| Sep 2019 | Aug 2022 | 153 | 68.3% | -53.0% | +254.1% |
| Sep 2022 | Nov 2022 | 8 | 13.6% | +40.8% | +520.0% |
| Average | 78 | — | +-23.3% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02